Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000

International Journal of Antimicrobial Agents

Volumn 23, Issue 4, 2004, Pages 356-361

  Koeth, L M ^a   Felmingham, D ^b   Jacobs, M R ^c   Rossi, F ^d  

^a Laboratory Specialists Inc   (United States)

^b GR Micro Ltd   (United Kingdom)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial resistance; Brazil; Haemophilus influenzae; Streptococcus pneumoniae; Surveillance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFDINIR; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STANDARD; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRAZIL; CHILD; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 1842739123     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.022     Document Type: Article

References (23)

1. Jones R. The impact of antimicrobial resistance: changing epidemiology of community-acquired respiratory-tract infections. Am. J. Health Syst. Pharm. 56:1999;S4-S11.
2. Jacobs M.R., Bajaksouzian S., Zilles A., Gengrong L., Pankuch G., Appelbaum P. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance Study. Antimicrob. Agents Chemother. 43:1999;1901-1908.
3. Felmingham D, Gruneberg RN and the Alexander Project Team. The Alexander Project 1996-1997: latest susceptibility results of an international study of bacterial pathogens from community acquired lower respiratory tract infections. J Chemother 2000;45:191-203.
4. Thornsberry C., Sahm D.F. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study. Chemotherapy. 46:2000;15-23.
5. Jacobs MR, Appelbaum PC and LASER Study Group. Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries. Int J Antimicrob Agents 2000;16:17-24.
6. Sader H.S., Sampaio J., Zoccoli C., Jones R.N. Results of the 1997 SENTRY antimicrobial surveillance program in three Brazilian medical centers. Braz. J. Infect. Dis. 3:1999;63-79.
7. Critchley I.A., Blosser R.S., Karlowsky J.A.et al. Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000. Braz. J. Infect. Dis. 5:2001;294-304.
8. Sessegolo J.F., Levin A.S., Levy C.E., Asensi M., Facklam R.R., Teixeira L.M. Distribution of serotypes and antimicrobial resistance of S. pneumoniae strains isolated in Brazil from 1998 to 1992. J. Clin. Microbiol. 32:1994;906-911.
9. Rossi F., Andreazzi D., Maffucci M., Pereira A.A. Susceptibility of S. pneumoniae to various antibiotics among strains isolated from patients and healthy carriers in different regions of Brazil (1999-2000). Braz. J. Infect. Dis. 5:2000;305-312.
10. Lopez-Vidal Y, Palavecino E, Rossi F and LASER Group. Prevalence of B-lactamase production in H. influenzae isolated in Latin America in 1998-1999: results of the LASER study. Int J Antimicrob Agents 2002;19:201-5.
11. Felmingham D, Grüneberg RN and the Alexander Project Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander project. J Antimicrob Chemother 1996;38:1-57.
12. National Committee for Clinical Laboratory Standards. Approved Standard M7-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Wayne, PA: NCCLS; 1997.
13. National Committee for Clinical Laboratory Standards. M100-S12 Performance standards for antimicrobial susceptibility testing. In: Proceedings of the 10th Informational Supplement, NCCLS, Wayne, PA; 2002.
14. Nightingale C.H. Pharmacokinetics and pharmacodynamics of newer macrolides. Pediatr. Infect. Dis. J. 16:1995;438-443.
15. Craig W.A., Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:1996;255-259.
16. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1998;1-10.
17. Jacobs M.R. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin. Microbiol. Infect. 7:2001;589-596.
18. Dagan R., Leibovitz E., Leiberman A., Yagupsky D. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr. Infect. Dis. J. 19:2000;S57-65.
19. Del-Alamo L., Sampaio J., Mirenda E.A., Sader H.S. Comparative in vitro activities of moxifloxacin (Bay 12-8039) and other antimicrobial agents against respiratory tract pathogens in Brazil. Braz. J. Infect. Dis. 3:1999;215-219.
20. Gales A, Sader H, Jones RN and SENTRY Participants Group (Latin America). Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY Antimicrobial Surveillance Program Medical Centers in Latin America (1999). Antimicrob Agents Chemother 2001;45:1463-66.
21. Dagan R., Klugman K.P., Craig W.A., Baquiero F. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J. Antimicrob. Chemother. 47:2001;129-140.
22. Jacobs M.R. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr. Infect. Dis. J. 19:2000;S47-56.
23. Berezin E.N., Carvalho E.S., Casagrande S., Brandileone M.C., Mimica I.M., Farhat C.K. S. pneumoniae penicillin non-susceptible strains in invasive infection in Sao Paolo, Brazil. Pediatr. Infect. Dis. J. 15:1996;1051-1052.